1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: The vote of no confidence against Bulgaria's government, despite being unsuccessful, hashighlighted the dissatisfaction of a large proportion of the population with proposed healthcare reforms. Anumber of recent controversies have lowered the public's opinion of its governance, but new legislationappears to be addressing the long-held issue of an over-reliance on private spending. Cost-containment willaffect revenue-generating opportunities for drugmakers, but generic medicines will gain market share.

Headline Expenditure Projections

- Pharmaceuticals: BGN2.71bn (USD1.54bn) in 2015 to BGN2.89bn (USD1.58bn) in 2016; +6.6% inlocal currency terms and +2.5% in US dollar terms. Forecast revised slightly downwards compared to theprevious quarter.

- Healthcare: BGN7.45bn (USD4.22bn) in 2015 to BGN7.85bn (USD4.28bn) in 2016; +5.4% in localcurrency terms and +1.5% in US dollar terms. Forecast increased compared to the previous quarter.

Table Of Contents

Bulgaria Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bulgaria 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q3 2016 29
Bulgaria Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 39
Pricing Regime 40
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Bulgaria 2010-2015) 48
Table: Healthcare Resources (Bulgaria 2010-2015) 48
Table: Healthcare Personnel (Bulgaria 2010-2015) 49
Table: Healthcare Activity (Bulgaria 2010-2015) 49
Table: NHIF Budget, 2014 53
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015 53
Research and Development 54
Table: Members Of ARPharM, 2014 54
Clinical Trials 55
Table: Cancer Incidence Rates, 2012-2035 58
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Retail Sector 61
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012 63
Company Profile 64
Sopharma 64
Demographic Forecast 68
Demographic Outlook 68
Table: Population Headline Indicators (Bulgaria 1990-2025) 69
Table: Key Population Ratios (Bulgaria 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Bulgaria 1990-2025) 70
Table: Population By Age Group (Bulgaria 1990-2025) 70
Table: Population By Age Group % (Bulgaria 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...

North America Syringes and Needles Market Outlook to 2021

North America Syringes and Needles Market Outlook to 2021

  • $ 5 995
  • Industry report
  • April 2016
  • by Global Data

North America Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "North America Syringes and Needles Market Outlook to 2021", provides key market data on the North America Syringes ...

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.